Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)
Clinical trial NCT04888585 · TERMINATED
Trial details
- NCT number
- NCT04888585
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-23
- Primary completion
- 2022-08-25
- Enrollment
- 473
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.